TransMedics Group, Inc. (TMDX) stock
TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3029% below fair value
$91.38−0.62 (-0.67%)
Close on Nov 13, 2026Market cap $3.17BP/E 25.0Yield 0.00%
TransMedics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
TransMedics's enterprise value was $2.73B on Nov 11, 2026, against $4.53B a year earlier. Over the last 5 years it ranged from $372.79M to $5.24B, with a median of $2.29B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.73B | -26.0% |
| 2025 | Dec 31, 2025 | $3.69B | +109.5% |
| 2024 | Dec 31, 2024 | $1.76B | -18.0% |
| 2023 | Dec 29, 2023 | $2.15B | +17.8% |
| 2022 | Dec 30, 2022 | $1.83B | +293.2% |
| 2021 | Dec 31, 2021 | $464.13M | +4.9% |
| 2020 | Dec 31, 2020 | $442.29M | +262.7% |
| 2019 | Dec 31, 2019 | $121.94M | – |
See a number that looks wrong?